Efficacy of Two Chlorhexidine Solutions to Control the Initial Subgingival Biofilm Formation
Efficacy of Two Clorhexidine Formulations to Control the Initial Subgingival Biofilm Formation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil
- University of Rio Grande do Sul
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age from 18 years;
- non-smokers;
- have good general health;
- present at least 20 natural teeth in the mouth, including the incisors, canines and premolars without restorations, crowns, gingival recession, anatomic defects, gingivitis e/or periodontitis.
Exclusion Criteria:
• positive history of using antibiotic e/or anti-inflammatory drugs in the month previous to the initial consultation;
- positive history of allergies at using Triclosan;
- pregnant or lactating patients;
- patients in use of fixed orthodontic appliance.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 0.12% Clorhexidine with alcohol
0.12% Clorhexidine with alcohol, 15ml every 12 hour for 4 days
|
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
Other Names:
Use of placebo every 12 hours for 04 days
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Other Names:
|
|
Experimental: 0.12% Clorhexidine without alcohol
0.12% Clorhexidine without alcohol, 15ml every 12 hour for 4 days
|
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
Other Names:
Use of placebo every 12 hours for 04 days
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Other Names:
|
|
Placebo Comparator: control
placebo 15ml every 12 hour for 4 days
|
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
Other Names:
Use of placebo every 12 hours for 04 days
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy of two clorhexidine formulations to Control the Initial Subgingival Biofilm Formation assessed by the plaque free zone index.
Time Frame: 24hours
|
The presence of scores 0, 1 or 2 of the index "Plaque Free Zone" will be recorded at baseline and at each 24 hours, during a period of 96 hours (4 days).
|
24hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Patricia Weidlich, PhD, Federal University of Rio Grande do Sul
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- URio Grande
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.